Access this insightful resource to learn more about AOF
T cell medium formulations. We explore results from a detailed evaluation of the offerings by top industry suppliers, with a look at key performance capabilities using cells from both healthy donors and diseased donors. The criteria for comparison included transduction efficiency, transduced early memory phenotype, cell expansion, and viability.
